196 related articles for article (PubMed ID: 36644541)
21. Aptamer-labeled PLGA nanoparticles for targeting cancer cells.
Aravind A; Varghese SH; Veeranarayanan S; Mathew A; Nagaoka Y; Iwai S; Fukuda T; Hasumura T; Yoshida Y; Maekawa T; Kumar DS
Cancer Nanotechnol; 2012; 3(1-6):1-12. PubMed ID: 26069492
[TBL] [Abstract][Full Text] [Related]
22. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
23. Stimuli-responsive magnetic silica-poly-lactic-co-glycolic acid hybrid nanoparticles for targeted cancer chemo-immunotherapy.
Gupta A; Niveria K; Chandpa HH; Singh M; Kumar V; Panda AK; Meena J
Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38347431
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
25. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
27. Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.
Leiva MC; Ortiz R; Contreras-Cáceres R; Perazzoli G; Mayevych I; López-Romero JM; Sarabia F; Baeyens JM; Melguizo C; Prados J
Sci Rep; 2017 Oct; 7(1):13506. PubMed ID: 29044153
[TBL] [Abstract][Full Text] [Related]
28. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Cui Y; Xu Q; Chow PK; Wang D; Wang CH
Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
[TBL] [Abstract][Full Text] [Related]
29. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
[TBL] [Abstract][Full Text] [Related]
30. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
[TBL] [Abstract][Full Text] [Related]
31. Evaluating Inhibitory Effects of Paclitaxel and Vitamin D
Khodaverdi S; Jafari A; Movahedzadeh F; Madani F; Yousefi Avarvand A; Falahatkar S
Adv Pharm Bull; 2020 Jan; 10(1):30-38. PubMed ID: 32002359
[No Abstract] [Full Text] [Related]
32. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
33. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
34. Optimization and Evaluation of Poly(lactide-
Haider M; Elsherbeny A; Jagal J; Hubatová-Vacková A; Saad Ahmed I
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32872639
[TBL] [Abstract][Full Text] [Related]
35. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
[TBL] [Abstract][Full Text] [Related]
36. Effect of Paclitaxel/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma.
Maleki H; Hosseini Najafabadi MR; Webster TJ; Hadjighassem MR; Sadroddiny E; Ghanbari H; Khosravani M; Adabi M
Int J Pharm; 2021 Jul; 604():120722. PubMed ID: 34022255
[TBL] [Abstract][Full Text] [Related]
37. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
38. Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer.
Houdaihed L; Evans JC; Allen C
Mol Pharm; 2018 Sep; 15(9):3672-3681. PubMed ID: 29863881
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of paclitaxel-loaded and folic acid-modified poly (lactic-co-glycolic acid) nano-micelles and in vitro anticancer effect on cervical cancer HeLa cells].
Li XJ; You Y; Zhang QL; Zhang BB; Yan L; Ou ZM; Zhang Y; Wang YJ; Tong Y; Liu DW; Wang JY
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2481-2488. PubMed ID: 34047094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]